11.18.11
Quanticate has appointed Dr. Daniel Chapple as vice president of business development and marketing. He will report to Quanticate’s chairman and chief executive officer David Underwood and will be based out of offices in the UK and Boston, MA. Most recently, Mr. Chapple was general manager at Cognizant’s Life Sciences BPO practice in London, UK.
Dr. Chapple will be responsible for working with the leadership team to further develop the Centralized Clinical Data Sciences solution, which is focused on the importance of data to successfully gain approval and market new products through the use of technology coupled with highly skilled statisticians, programmers, data managers, medical writers and pharmacovigilance experts.
Prior to joining the company, Dr. Chapple served in a variety of leadership positions at Cognizant, ICON Clinical Research and MDS Pharma Services.
“Daniel’s experience in business development leadership and extensive knowledge of the clinical CRO space both at full service CROs and specialist BPOs gives him a firm foundation for this role,” said Mr. Underwood. “He is an exceptional leader who has helped support companies in developing solutions in the pharmaceutical, biotechnology and medical device sectors. His customer-focused orientation, self-awareness, and strong business acumen skills make him a good fit as part of our executive management team.”
Dr. Chapple will be responsible for working with the leadership team to further develop the Centralized Clinical Data Sciences solution, which is focused on the importance of data to successfully gain approval and market new products through the use of technology coupled with highly skilled statisticians, programmers, data managers, medical writers and pharmacovigilance experts.
Prior to joining the company, Dr. Chapple served in a variety of leadership positions at Cognizant, ICON Clinical Research and MDS Pharma Services.
“Daniel’s experience in business development leadership and extensive knowledge of the clinical CRO space both at full service CROs and specialist BPOs gives him a firm foundation for this role,” said Mr. Underwood. “He is an exceptional leader who has helped support companies in developing solutions in the pharmaceutical, biotechnology and medical device sectors. His customer-focused orientation, self-awareness, and strong business acumen skills make him a good fit as part of our executive management team.”